English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Progress in oncolytic viruses modified with nanomaterials for intravenous application Review article
2023
Authors:  Chen, Liting;  Ma, Zhijun;  Xu, Chen;  Xie, Youbang;  Ouyang, Defang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:5  IF:5.6/5.9 | Submit date：2024/01/10
Oncolytic Virus  Nanomaterials  Drug Delivery  Tumor Treatment  Intravenous Application  
Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas Journal article
Li, Ping, Chen, Fengyang, Zheng, Jingbin, Yang, Yang, Li, Yuan, Wang, Yifei, Chen, Xin*. Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas[J]. Cancer Biology and Medicine, 2021, 18(4), 1010-1020.
Authors:  Li, Ping;  Chen, Fengyang;  Zheng, Jingbin;  Yang, Yang;  Li, Yuan; et al.
Favorite | TC[WOS]:9 TC[Scopus]:8  IF:5.6/5.9 | Submit date：2021/12/08
Bleomycin  Cyclophosphamide  Tnfr2  Tregs  Tumor Necrosis Factor